Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

SAFER Karachi - Un intervento per la prevenzione delle cadute (SAFER)

8 novembre 2026 aggiornato da: Sonia Sameen, Aga Khan University

SAFER Karachi: Rafforzamento di un Intervento Adattato di Prevenzione delle Cadute per la Resilienza negli Anziani - Uno Studio Pilota a Karachi

The goal of this pilot study is to evaluate the feasibility, acceptability, and short-term effects of a culturally adapted and strengthened fall prevention program in older adults aged 60 years and above living in urban Karachi, Pakistan. The study aims to understand whether a structured, community-based intervention can improve mobility, confidence, and overall well-being while reducing the risk of falls.

The main questions it aims to answer are:

  1. Is the adapted and strengthened fall prevention program feasible and acceptable for older adults in Karachi?
  2. Does participation in the program improve mobility, balance, fall-related self-efficacy, and psychological distress among participants?

Participants will:

  1. Take part in a 7-week group-based fall prevention program that includes strength and balance exercises, home safety education, medication awareness, and behavioral strategies
  2. Receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence
  3. Attend a booster session after 3 months to support continued engagement
  4. Complete assessments at baseline and at Week 8 (endline), including mobility, cognitive function, quality of life, and psychological distress
  5. Receive telephone follow-up calls for up to 6 months after the intervention to monitor adherence to recommended practices

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Falls are a major public health concern among older adults and are a leading cause of injury, disability, and loss of independence worldwide. The burden is particularly high in low- and middle-income countries (LMICs), where over 80% of fall-related deaths occur. In Pakistan, and especially in urban settings like Karachi, older adults face compounded risks due to limited access to geriatric care, inadequate home safety infrastructure, financial constraints, and reliance on informal caregiving systems. Despite this growing burden, fall prevention remains underexplored and under-implemented in the local context.

Most evidence-based fall prevention interventions have been developed and tested in high-income countries, raising concerns about their applicability in LMIC settings due to differences in environmental conditions, health system structures, cultural norms, and resource availability. There is a critical need to adapt and evaluate such interventions to ensure they are feasible, acceptable, and effective within the local context.

The SAFER Karachi study (Strengthening an Adapted Fall Prevention Intervention for Resilience in Older Adults) is a pilot quasi-experimental study designed to address this gap. The study aims to adapt, strengthen, and evaluate a culturally relevant fall prevention intervention for community-dwelling older adults aged 60 years and above in urban Karachi.

The intervention is based on the evidence-based Stepping On program, a multi-component fall prevention strategy that integrates strength and balance training, environmental safety education, medication awareness, and behavioural change approaches to improve self-efficacy and reduce fall risk. While the core structure of the program will be retained, context-specific adaptations and strengthening measures will be incorporated to enhance feasibility, safety, and relevance in a low-resource urban setting. These include standardized facilitator training, physiotherapist-informed delivery of exercise components, integration of supportive tools to improve adherence, and minor refinements informed by formative research and local implementation considerations.

The study will use a pre-test and post-test quasi-experimental design and will enroll approximately 75 older adults from selected urban communities in Karachi. The intervention will be delivered over a 7-week period through structured group sessions led by trained facilitators. Each session will focus on key components of fall prevention, including physical exercises, home hazard identification, medication-related risk awareness, vision and footwear considerations, and behavioral strategies to support long-term adherence. Peer interaction and social support will be emphasized to enhance engagement and sustainability.

Following the weekly group sessions, participants will receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence, followed by a booster session at 3 months post-intervention to support continued engagement. Telephone follow-ups will continue for up to 6 months post-intervention to monitor adherence to recommended practices.

The primary focus of this pilot study is to assess the feasibility and acceptability of implementing the adapted intervention in Karachi's urban community settings. Feasibility will be evaluated through indicators such as recruitment rates, retention, session attendance, and adherence to intervention components. Acceptability will be assessed through participant feedback collected in focus group discussions and facilitator evaluations, providing insights into user experience and implementation challenges.

In addition, the study will assess short-term changes in selected health and functional outcomes at baseline and endline (Week 8), including mobility and balance, fall-related self-efficacy, cognitive function, psychological distress, nutritional status, sleep quality, activities of daily living, quality of life, and adherence to home and community safety modifications. Falls will be recorded by self-report, providing preliminary data to inform future research, although the study is not powered to detect long-term reductions in fall incidence.

Data collection will include baseline and endline assessments using standardized and validated tools, as well as qualitative interviews during the formative phase and focus group discussions after the intervention to explore participant experiences, barriers, facilitators, and recommendations for improvement. These findings will be used to further refine the intervention and enhance its contextual fit.

This pilot study is designed to generate critical preliminary evidence to inform a larger, fully powered trial. By identifying key implementation challenges, participant engagement patterns, and early outcome trends, the study will contribute to the development of a scalable, culturally appropriate fall prevention model for Pakistan and similar LMIC settings.

Ultimately, the SAFER Karachi study seeks to shift the focus from reactive management of fall-related injuries to proactive, community-based prevention strategies. By improving mobility, confidence, and overall well-being among older adults, this intervention has the potential to enhance independence and quality of life while reducing the burden on families and health systems.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

75

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Sindh
      • Karachi, Sindh, Pakistan, 74800
        • Aga Khan University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

60 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Older adults, aged 60 years and above, residing in urban Karachi
  • Able to ambulate independently, with or without a walking stick

Exclusion Criteria:

  • Individuals who are unable to stand independently, or requiring mobility assistive devices other than a walking stick
  • Individuals who are bedbound or homebound and require full-time assistance
  • Individuals with diagnosed cognitive impairment or dementia

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Intervention Arm

Participants will receive a 7-week group-based fall prevention intervention adapted for the local context. The program focuses on improving strength, balance, and safety awareness among older adults, with additional follow-up through a home visit and booster session to support sustained behaviour change.

This intervention is a culturally adapted and contextually strengthened version of the evidence-based Stepping On fall prevention program, tailored for older adults in a low-resource urban setting. Unlike standard implementations, this version incorporates context-specific modifications based on local environmental, social, and health system realities in Karachi.

Key distinguishing features include structured facilitator training to ensure standardized delivery, physiotherapist-informed guidance for exercise components to enhance safety, and integration of supportive tools to improve participant adherence and engagement. The intervention also includes follow-up reinforcement through home visits and a booster session to support sustained behaviour change.

These adaptations are designed to improve feasibility, acceptability, and scalability of the intervention within resource-constrained settings while retaining the core evidence-based components of the original program.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility of the Adapted Fall Prevention Intervention: Recruitment Rate
Lasso di tempo: During enrollment, before the intervention starts

Proportion of eligible participants enrolled in the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

During enrollment, before the intervention starts
Feasibility of the Adapted Fall Prevention Intervention: Retention Rate
Lasso di tempo: From enrolment to endline assessment (Week 8)

Proportion of enrolled participants who complete the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

From enrolment to endline assessment (Week 8)
Feasibility of the Adapted Fall Prevention Intervention: Session Attendance
Lasso di tempo: From baseline to the end of the intervention (Weeks 1-7)

Number or proportion of intervention sessions attended by participants. Reported as a percentage or count, with higher values indicating better adherence.

From baseline to the end of the intervention (Weeks 1-7)
Feasibility of the Adapted Fall Prevention Intervention: Adherence to Intervention
Lasso di tempo: From Week 1 to 6 months post-intervention

Extent to which participants follow prescribed intervention components. Reported as a proportion or score, with higher values indicating better adherence.

From Week 1 to 6 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Acceptability Score
Lasso di tempo: From baseline to the booster session, 3 months post-intervention

Measured using a Likert-scale questionnaire (e.g., 1-5), where higher scores indicate greater acceptability of the intervention.

From baseline to the booster session, 3 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Participant Experience (Qualitative)
Lasso di tempo: At the end of the intervention and follow-up (up to 1 month)

Assessed through qualitative interviews exploring participant experiences and perceptions of the intervention. Data will be analyzed thematically.

At the end of the intervention and follow-up (up to 1 month)
Acceptability of the Adapted Fall Prevention Intervention: Facilitator Evaluation
Lasso di tempo: Weeks 1-7 (end of each session and end of the intervention)

Facilitator-reported acceptability will be assessed using a structured questionnaire adapted from the Acceptability of Intervention Measure (AIM), a validated 4-item scale evaluating appropriateness, satisfaction, appeal, and willingness to continue. Items are rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). A mean score (range: 1-5) will be calculated, with higher scores indicating greater acceptability.

In addition, facilitators will complete a Structured Intervention Delivery Assessment Checklist covering ease of delivery, fidelity, and participant engagement. Items will be rated on a 5-point Likert scale (1 = poor/not at all to 5 = excellent/to a great extent). Mean domain and overall scores (range: 1-5) will be calculated, with higher scores indicating better implementation. Responses will be summarized descriptively.

Weeks 1-7 (end of each session and end of the intervention)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Short-term Functional and Psychosocial Outcomes: Activities of Daily Living (ADL)
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Assessed using the Katz Index of Independence in Activities of Daily Living. Scores range from 0 to 6, with higher scores indicating greater independence.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Fall-Related Self-Efficacy
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Measured using the Short Falls Efficacy Scale-International (Short FES-I). Scores range from 0 to 10 (or tool-specific range), with higher scores indicating greater confidence in performing activities without falling.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Mobility and Balance
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Assessed using the Timed Up and Go (TUG) test. Performance is measured in seconds, with shorter times indicating better mobility and balance.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Nutritional Status
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Measured using the Mini Nutritional Assessment-Short Form (MNA-SF). Scores range from 0 to 30, with higher scores indicating better nutritional status.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Sleep Quality
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Assessed using the Pittsburgh Sleep Quality Index-Short (PSQI-Short). Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Quality of Life
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Measured using the Older People's Quality of Life Questionnaire (OPQOL). Domain scores range from 0 to 100, with higher scores indicating better quality of life.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Cognitive Function
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Assessed using the Mini Montreal Cognitive Assessment (Mini MoCA). Scores range from 0 to 30, with higher scores indicating better cognitive function.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Psychological Distress
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Measured using the Kessler Psychological Distress Scale (K10). Scores range from 10 to 50, with higher scores indicating greater psychological distress.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Adherence to Safety Modifications
Lasso di tempo: Baseline (Week 0) and endline (Week 8)

Adherence to recommended home and community safety modifications will be assessed using a structured Self-Reported Safety Modification Adherence Checklist developed for this study based on standard fall prevention guidelines from multiple sources, including the Otago guidelines, WHO, and more. The checklist will include multiple items covering home environment modifications, use of assistive devices, and safe mobility practices. Each item will be scored as 0 (not implemented), 1 (partially implemented), or 2 (fully implemented).

A total adherence score will be calculated by summing item responses, with scores ranging from 0 to the maximum possible based on applicable items; higher scores indicate greater adherence. Adherence may also be expressed as a proportion (%) of recommended modifications implemented.

Baseline (Week 0) and endline (Week 8)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Fall Incidence
Lasso di tempo: Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Number of self-reported falls (ProFaNE consensus definition of falls)

Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Sonia Sameen, MSc., Aga Khan University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 settembre 2025

Completamento primario (Effettivo)

30 giugno 2026

Completamento dello studio (Effettivo)

31 agosto 2026

Date di iscrizione allo studio

Primo inviato

19 marzo 2026

Primo inviato che soddisfa i criteri di controllo qualità

27 marzo 2026

Primo Inserito (Effettivo)

31 marzo 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 novembre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2025-11554-35416
  • D43TW007292 (Sovvenzione/contratto NIH degli Stati Uniti)
  • 2025 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data (IPD) underlying the results reported in this study will be made available to qualified researchers upon reasonable request. Data will be shared after publication of the primary study results and will include variables necessary to reproduce the findings.

All data sharing will be subject to approval by the principal investigator and the Aga Khan University Ethics Review Committee, and will require a data sharing agreement to ensure confidentiality, ethical use, and compliance with institutional policies.

Periodo di condivisione IPD

Data will be available beginning 6 months after publication of the primary results and will remain available for up to 3 years.

Criteri di accesso alla condivisione IPD

Access will be granted to researchers with a methodologically sound proposal. Requests should be directed to the principal investigator and will be reviewed based on scientific merit, ethical considerations, and feasibility.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .